在三阴性乳腺癌中,BRD4S,LOXL2和MED1之间的相互作用驱动细胞周期转录
Laura Pascual-Reguant1, Queralt Serra-Camprubí2, Debayan Datta1
1Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
同时抑制LOXL2和BRD4可以协同抑制三阴性乳腺癌 (TNBC) 的扩散. 准LOXL2-BRD4相互作用为TNBC治疗提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 三重阴性乳腺癌 (TNBC) 往往对单剂疗法具有抗性.
- 有针对性的组合方法对于克服TNBC治疗耐药性至关重要.
研究的目的:
- 研究LOXL2和BRD4同时抑制对TNBC增殖的协同效应.
- 阐明所观察到的协同效应背后的分子机制.
主要方法:
- 进行了体外和体内研究,以评估TNBC增殖.
- 机制研究涉及分析LOXL2与BRD4S,MED1和B-MyB.的相互作用.
- 药物协同抑制被用来评估对转录焦点和基因表达的影响.
主要成果:
- 同时抑制LOXL2和BRD4的协同作用限制了TNBC的扩散.
- 发现LOXL2与细胞核中的BRD4S,MED1和B-MyB相互作用,调节细胞周期基因转录.
- 药物联合抑制降低了BRD4核焦点和BRD4-MED1局部化,抑制了细胞周期基因转录.
结论:
- 同时抑制LOXL2和BRD4是TNBC治疗的一个有希望的协同策略.
- 针对BRD4S和LOXL2之间的相互作用可能会导致TNBC开发新的治疗策略.
更多相关视频
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11:47Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer
Published on: February 8, 2013
相关概念视频
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity
Cells Coordinate Growth and Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle
